Hey followers

Please participate in this “Acute Dialysis” Survey

👉🏼 Link to survey https://t.co/upIHZeP0l0

15 33

Capillary leak syndrome: etiologies, pathophysiology and management ca. 2017 from

👉 https://t.co/CTl5vmyuGA

28 43

Intrarenal Doppler Renal Venous Stasis Index Correlates With Acute Syndrome in Patients With Acute Decompensated
🔗https://t.co/F48QNLM245

26 70

The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis ca. 2022 from

👉🏼 https://t.co/U3SF9RxjvJ

33 96

CHERNEY: Characteristics of participants enrolled in renal outcome trials involving SGLT2 inhibitors

EMPA-KIDNEY ⏳⌛️
🔲 +/- Type 2 DM (T2D)
🔲 eGFR ~ 20
🔲 Low levels of albuminuria
🇲🇾

👉 https://t.co/R8rVmrqwAf

20 35

Paving the Path toward Porcine Organs for Transplantation ca. 2017 from

https://t.co/UrICYOyzuY

5 17

The sustained expression of AQP2 in the apical plasma membrane, in combination with basolateral expression of AQP3 and AQP4, provides a pathway for "osmotic reabsorption of water"

https://t.co/7UxfZVUU91

4 7

AVP binds to the V2 receptor & enhances NaCl reabsorption (in the TAL) which increases interstitial osmolality

AVP also stimulates AQP2 translocation to the apical plasma membrane from intracellular storage vesicles

https://t.co/7UxfZVUU91

7 11

AVP is synthesized in the paraventricular & supraoptic nuclei of the hypothalamus

These nuclei respond to various stimuli:
SupraOPTIC – Osmotic
ParaVENTRICULAR - Volume (Hemodynamic mediated)

H/T

https://t.co/j3WGlMP7Sq

18 47

CHERNEY: Characteristics of participants enrolled in renal outcome trials involving SGLT2 inhibitors

EMPA-KIDNEY (still ongoing)
🔲 +/- Type 2 Diabetes
🔲 eGFR ~ 20
🔲 Low levels of albuminuria


https://t.co/VEBssUX9pV

4 5